NCT05607719View on ClinicalTrials.gov

Inhaled Corticosteroids (ICS) on Pulmonary Endothelial Function in COPD

PHASE2RecruitingINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

April 11, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

March 30, 2026

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

Bevespi

Two puffs twice a day

DRUG

Bretzri

Two puffs twice a day

Trial Locations (1)

33136

RECRUITING

University of Miami, Miami

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

University of Miami

OTHER